in an attempt to improve the poor outlook for children with t-cell leukemia ( t-all ) , the southwest oncology group , pediatric division , used a modified lsa2-l2 multidrug regimen to treat 53 patients with e-rosette-positive t-all .
C0023492
t-cell leukemia
C0023493
t-all